Filter
2926
Filtered Results: 2926
Text search:
Impact
analysis
of
tuberculosis
Featured
Recommendations
250
New Publications
791
Language
Document type
No document type
1763
Studies & Reports
562
Guidelines
301
Manuals
115
Strategic & Response Plan
114
Fact sheets
23
Training Material
19
Situation Updates
17
Infographics
6
Resource Platforms
5
Brochures
1
Countries / Regions
Global
138
India
90
Kenya
83
Western and Central Europe
68
South Africa
68
Uganda
64
Ethiopia
61
Nigeria
59
Malawi
56
Nepal
55
Zambia
52
Liberia
51
Tanzania
48
Rwanda
47
Africa
47
Sierra Leone
45
Namibia
44
Myanmar / Burma
44
Latin America and the Carribbean
42
Ukraine
40
Ghana
37
Bangladesh
36
Eastern Europe
34
Lesotho
31
Asia
29
Cambodia
23
South–East Asia Region
23
Zimbabwe
22
Philippines
21
Mozambique
20
Russia
19
Indonesia
19
Senegal
18
Botswana
18
Colombia
16
Congo, Democratic Republic of
14
East and Southern Africa
13
South Sudan
13
Haiti
12
Syria
11
Burkina Faso
11
Peru
9
Germany
9
Moldova
9
Pakistan
9
Tajikistan
8
Cameroon
8
Albania
8
Venezuela
8
West and Central Africa
8
Argentina
8
Benin
7
Afghanistan
7
Eastern Europe and Central Asia
7
Thailand
6
Brazil
6
Yemen
6
Georgia
6
Eswatini/ Swaziland
6
Timor Leste/ East Timor
5
Chile
5
Guinea
5
Middle East and North Africa
5
North America
5
Sudan
5
Somalia
5
El Salvador
4
Jordan
4
Paraguay
4
Lebanon
4
Vietnam
4
Sri Lanka
4
North Macedonia
3
Mexico
3
China
3
Iran
3
Laos
3
Jamaica
3
Bolivia
3
Papua New Guinea
3
Central African Republic
3
Honduras
3
Madagascar
3
Gambia
2
Estonia
2
Morocco
2
Bulgaria
2
USA
2
Hungary
2
Saudi Arabia
2
Western Pacific Region
2
Turkmenistan
2
Japan
2
Nicaragua
2
Romania
2
Palestine
2
Poland
2
Mali
2
Bhutan
2
Iraq
2
Ecuador
2
Guatemala
2
North Korea
1
Togo
1
Kyrgyzstan
1
Burundi
1
Mongolia
1
Qatar
1
Armenia
1
Dominican Republic
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Djibouti
1
Egypt
1
Slovakia
1
Greece
1
Chad
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
1174
Clinical Guidelines
205
Public Health
167
Key Resources
106
Women & Child Health
89
Pharmacy & Technologies
33
Capacity Building
20
Toolboxes
HIV
453
TB
438
COVID-19
148
AMR
129
Health Financing Toolbox
80
Mental Health
72
NCDs
61
Global Health Education
57
Rapid Response
54
Planetary Health
51
NTDs
51
Pharmacy
46
Caregiver
42
Conflict
40
Malaria
39
Refugee
35
Ebola & Marburg
32
Disability
29
Polio
19
Natural Hazards
15
Cholera
3
Specific Hazards
2
Social Ethics
2
South Sudan
1
Zika
1
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Background: Community Health Workers (CHWs) have a positive impact on the provision of community-based
primary health care through screening, treatment, referral, psychosocial support, and accompaniment. With a
broad scope of work, CHW programs must balance the breadth and depth of tasks to mainta...
Countries reported disruptions in all health-care settings. In more than half of countries surveyed, many people are still unable to access care at the primary care and community care levels. Significant disruptions have also been reported in emergency care, particularly concerning given the impact...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)...
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Lesotho’s predominantly rural population faces significant health challenges within a setting of inadequate human resources for health. It is essential that nurses and nurse-midwives, who together make up the largest health workforce in the country, be adequately prepared to address Lesotho’s He...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122
Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
USAID/KENYA Evaluation Services and Program Support (ESPS)
The United States Agency for International Development (USAID) has a solid track record of supporting health and development initiatives in Kenya. AIDS, Population, and Health Integrated Assistance (APHIA) is the agency’s flagship hea...
The United States Agency for International Development (USAID) has a solid track record of supporting health and development initiatives in Kenya. AIDS, Population, and Health Integrated Assistance (APHIA) is the agency’s flagship hea...
Zambia is facing a severe economic crisis marked by high inflation, increasing poverty and a heavy debt burden that is straining both its fiscal stability and progress in health outcomes. By 2020, the country's external debt reached United States dollars (USD) 12.7 billion, representing 108% of the ...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Substantial progress in the fight against HIV has been made over the past decade. Advances in HIV prevention, testing, and treatment have been matched by declines in HIV incidence and HIV-related deaths. The success of Botswana reaching the 95-95-95 targets, despite resource limitations, points to a...
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV patients. Early detection and effective treatment are essential to preventing TB...
